Allianz Asset Management Gmb H Replimune Group, Inc. Transaction History

Allianz Asset Management Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$28.5 - $39.37 $1.17 Million - $1.62 Million	-41,055 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$30.22 - $45.57 $147,957 - $223,110	4,896 Added 13.54%	41,055 $1.25 Million
Q4 2020 Feb 16, 2021	BUY	$23.5 - $52.65 $460,036 - $1.03 Million	19,576 Added 118.05%	36,159 $1.38 Million
Q3 2020 Nov 13, 2020	SELL	$18.85 - $27.0 $26,767 - $38,340	-1,420 Reduced 7.89%	16,583 $382,000
Q2 2020 Aug 14, 2020	BUY	$9.76 - $25.95 $175,709 - $467,177	18,003 New	18,003 $447,000

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $693M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.